ABSTRACT: Thalidomide, a drug once thought to have no clinical benefit due to its significant toxicity, has now become a potential agent for the treatment of hematologic malignancies and some solid tumors.
ABSTRACT: Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by a translocation between chromosomes 9 and 22, forming the Philadelphia (Ph) chromosome.
ABSTRACT: Cancer, chemotherapy, and surgery are conditions that increase the risk of the development of venous thromboembolism (VTE), a common and potentially life-threatening condition.